Flavivirus cell entry and membrane fusion

Viruses

Volumn 3, Issue 2, 2011, Pages 160-171

  Smit, Jolanda M ^a   Moesker, Bastiaan ^a   Rodenhuis Zybert, Izabela ^a   Wilschut, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anionic lipids; Cell entry; Dengue; Flavivirus; Membrane fusion; Negatively charged lipids; Receptor; West nile virus

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN E; LIPID;

ARTICLE; BINDING AFFINITY; CELL MATURATION; COATED VESICLE; DENGUE VIRUS; ENDOCYTOSIS; FLAVIVIRUS; MEMBRANE FUSION; NONHUMAN; PARTICLE SIZE; PH; PROTEIN CONFORMATION; RECEPTOR BINDING; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS PARTICLE;

CELL MEMBRANE; DENGUE; DENGUE VIRUS; ENDOCYTOSIS; ENDOSOMES; HUMANS; MEMBRANE FUSION; MEMBRANE LIPIDS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; WEST NILE FEVER; WEST NILE VIRUS;

DENGUE VIRUS; FLAVIVIRUS; WEST NILE VIRUS;

EID: 79952140351     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3020160     Document Type: Article

References (90)

1. Zaitseva, E.; Yang, S.T.; Melikov, K.; Pourmal, S.; Chernomordik, L.V. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS. Pathog. 2010, 6, e1001131.
2. World Health Organization. Dengue fact sheet, 2009. Available online: http://www.who.int/mediacentre/factsheets/fs117/en/ (assessed Jan 2011).
3. Gubler, D.J. Dengue/dengue haemorrhagic fever: history and current status. Novartis. Found. Symp. 2006, 277, 3-16.
4. Burke, D.S.; Monath, T.P. Flaviviruses. in Fields Virology; Knipe, D.M., Howley, P.M, Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2001; Volume 1; pp 1043-1125.
5. Lindenbach, B.D.; Rice, C.M. Molecular biology of flaviviruses. Adv. Virus Res. 2003, 59, 23-61.
6. Kuhn, R.J.; Zhang, W.; Rossmann, M.G.; Pletnev, S.V.; Corver, J.; Lenches, E.; Jones, C.T.; Mukhopadhyay, S.; Chipman, P.R.; Strauss, E.G.; Baker, T.S.; Strauss, J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108, 717-725.
7. Zhang, W.; Chipman, P.R.; Corver, J.; Johnson, P.R.; Zhang, Y.; Mukhopadhyay, S.; Baker, T.S.; Strauss, J.H.; Rossmann, M.G.; Kuhn, R.J. Visualization of membrane protein domains by cryoelectron microscopy of dengue virus. Nat. Struct. Biol. 2003, 10, 907-912.
8. Rey, F.A.; Heinz, F.X.; Mandl, C.; Kunz, C.; Harrison, S.C. The envelope glycoprotein from tickborne encephalitis virus at 2 Å resolution. Nature 1995, 375, 291-298.
9. Mukhopadhyay, S.; Kuhn, R.J.; Rossmann, M.G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005, 3, 13-22.
10. Zhang, Y.; Corver, J.; Chipman, P.R.; Zhang, W.; Pletnev, S.V.; Sedlak, D.; Baker, T.S.; Strauss, J.H.; Kuhn, R.J.; Rossmann, M.G. Structures of immature flavivirus particles. EMBO J. 2003, 22, 2604-2613.
11. Rodenhuis-Zybert, I.A.; Wilschut, J.; Smit, J.M. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol. Life Sci. 2010, 67, 2773-2786.
12. Chen, Y.; Maguire, T.; Hileman, R.E.; Fromm, J.R.; Esko, J.D.; Linhardt, R.J.; Marks, R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 1997, 3, 866-871.
13. Germi, R.; Crance, J.M.; Garin, D.; Guimet, J.; Lortat-Jacob, H.; Ruigrok, R.W.; Zarski, J.P.; Drouet, E. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 2002, 292, 162-168.
14. Hilgard, P.; Stockert, R. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 2000, 32, 1069-1077.
15. Chen, H.L.; Her, S.Y.; Huang, K.C.; Cheng, H.T.; Wu, C.W.; Wu, S.C.; Cheng, J.W. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers 2010, 94, 331-338.
16. Kozlovskaya, L.I.; Osolodkin, D.I.; Shevtsova, A.S.; Romanova, L.I.; Rogova, Y.V.; Dzhivanian, T.I.; Lyapustin, V.N.; Pivanova, G.P.; Gmyl, A.P.; Palyulin, V.A.; Karganova, G.G. GAGbinding variants of tick-borne encephalitis virus. Virology 2010, 398, 262-272.
17. Lee, E.; Lobigs, M. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. J. Virol. 2008, 82, 6024-6033.
18. Mandl, C.W.; Kroschewski, H.; Allison, S.L.; Kofler, R.; Holzmann, H.; Meixner, T.; Heinz, F.X. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 2001, 75, 5627-5637.
19. Reyes-Del, V.J.; Chavez-Salinas, S.; Medina, F.; del Angel, R.M. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 2005, 79, 4557-4567.
20. Aoki, C.; Hidari, K.I.; Itonori, S.; Yamada, A.; Takahashi, N.; Kasama, T.; Hasebe, F.; Islam, M.A.; Hatano, K.; Matsuoka, K.; et al. Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2. J. Biochem. 2006, 139, 607-614.
21. Chen, Y.C.; Wang, S.Y.; King, C.C. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J. Virol. 1999, 73, 2650-2657.
22. Jindadamrongwech, S.; Thepparit, C.; Smith, D.R. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 2004, 149, 915-927.
23. Thepparit, C.; Smith, D.R. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J. Virol. 2004, 78, 12647-12656.
24. Lozach, P.Y.; Burleigh, L.; Staropoli, I.; Navarro-Sanchez, E.; Harriague, J.; Virelizier, J.L.; Rey, F.A.; Despres, P.; Renzana-Seisdedos, F.; Amara, A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 2005, 280, 23698-23708.
25. Navarro-Sanchez, E.; Altmeyer, R.; Amara, A.; Schwartz, O.; Fieschi, F.; Virelizier, J.L.; renzana-Seisdedos, F.; Despres, P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 2003, 4, 723-728.
26. Tassaneetrithep, B.; Burgess, T.H.; Granelli-Piperno, A.; Trumpfheller, C.; Finke, J.; Sun, W.; Eller, M.A.; Pattanapanyasat, K.; Sarasombath, S.; Birx, D.L.; et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003, 197, 823-829.
27. Miller, J.L.; de Wet, B.J.; Martinez-Pomares, L.; Radcliffe, C.M.; Dwek, R.A.; Rudd, P.M.; Gordon, S. The mannose receptor mediates dengue virus infection of macrophages. PLoS. Pathog. 2008, 4, e17.
28. Chen, S.T.; Lin, Y.L.; Huang, M.T.; Wu, M.F.; Cheng, S.C.; Lei, H.Y.; Lee, C.K.; Chiou, T.W.; Wong, C.H.; Hsieh, S.L. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008, 453, 672-676.
29. Mercado-Curiel, R.F.; Esquinca-Aviles, H.A.; Tovar, R.; az-Badillo, A.; Camacho-Nuez, M.; Munoz, M.L. The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells. BMC. Microbiol. 2006, 6, 85.
30. Yazi, M.M.; Salas-Benito, J.S.; Lanz-Mendoza, H.; Hernandez-Martinez, S.; del Angel, R.M. A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein. Am. J. Trop. Med. Hyg. 2002, 67, 76-84.
31. Pokidysheva, E.; Zhang, Y.; Battisti, A.J.; Bator-Kelly, C.M.; Chipman, P.R.; Xiao, C.; Gregorio, G.G.; Hendrickson, W.A.; Kuhn, R.J.; Rossmann, M.G. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006, 124, 485-493.
32. Davis, C.W.; Nguyen, H.Y.; Hanna, S.L.; Sanchez, M.D.; Doms, R.W.; Pierson, T.C. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 2006, 80, 1290-1301.
33. Davis, C.W.; Mattei, L.M.; Nguyen, H.Y.; nsarah-Sobrinho, C.; Doms, R.W.; Pierson, T.C. The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (dendritic cell-specific ICAM-3 grabbing nonintegrin). J. Biol. Chem. 2006, 281, 37183-37194.
34. Chu, J.J.; Ng, M.L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J. Biol. Chem. 2004, 279, 54533-54541.
35. Lee, J.W.; Chu, J.J.; Ng, M.L. Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin. J. Biol. Chem. 2006, 281, 1352-1360.
36. Medigeshi, G.R.; Hirsch, A.J.; Streblow, D.N.; Nikolich-Zugich, J.; Nelson, J.A. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J. Virol. 2008, 82, 5212-5219.
37. van der Schaar, H.M.; Rust, M.J.; Chen, C.; van der Ende.-Metselaar; Wilschut, J.; Zhuang, X.; Smit, J.M. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS. Pathog. 2008, 4, e1000244.
38. Ishak, R.; Tovey, D.G.; Howard, C.R. Morphogenesis of yellow fever virus 17D in infected cell cultures. J. Gen. Virol. 1988, 69, 325-335.
39. Ng, M.L.; Lau, L.C. Possible involvement of receptors in the entry of Kunjin virus into Vero cells. Arch. Virol. 1988, 100, 199-211.
40. Nawa, M.; Takasaki, T.; Yamada, K.; Kurane, I.; Akatsuka, T. Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J. Gen. Virol. 2003, 84, 1737-1741.
41. Chu, J.J.; Ng, M.L. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 2004, 78, 10543-10555.
42. Chu, J.J.; Leong, P.W.; Ng, M.L. Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells. Virology 2006, 349, 463-475.
43. Acosta, E.G.; Castilla, V.; Damonte, E.B. Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell Microbiol. 2009, 11, 1533-1549.
44. Krishnan, M.N.; Sukumaran, B.; Pal, U.; Agaisse, H.; Murray, J.L.; Hodge, T.W.; Fikrig, E. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J. Virol. 2007, 81, 4881-4885.
45. Harrison, S.C. The pH sensor for flavivirus membrane fusion. J. Cell Biol. 2008, 183, 177-179.
46. Stiasny, K.; Fritz, R.; Pangerl, K.; Heinz, F.X. Molecular mechanisms of flavivirus membrane fusion. Amino Acids 2009. doi: 10.1007/s00726-009-0370-4.
47. Fritz, R.; Stiasny, K.; Heinz, F.X. Identification of specific histidines as pH sensors in flavivirus membrane fusion. J. Cell Biol. 2008, 183, 353-361.
48. Nelson, S.; Poddar, S.; Lin, T.Y.; Pierson, T.C. Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the histidine switch hypothesis. J. Virol. 2009, 83, 12631-12635.
49. Mukhopadhyay, S.; Kuhn, R.J.; Rossmann, M.G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005, 3, 13-22.
50. Liao, M.; Sanchez-San, M.C.; Zheng, A.; Kielian, M. In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J. Virol. 2010, 84, 5730-5740.
51. Corver, J.; Ortiz, A.; Allison, S.L.; Schalich, J.; Heinz, F.X.; Wilschut, J. Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology 2000, 269, 37-46.
52. Gollins, S.W.; Porterfield, J.S. pH-dependent fusion between the flavivirus West Nile and liposomal model membranes. J. Gen. Virol. 1986, 67, 157-166.
53. Moesker, B.; Rodenhuis-Zybert, I.A.; Meijerhof, T.; Wilschut, J.; Smit, J.M. Characterization of the functional requirements of West Nile virus membrane fusion. J. Gen. Virol. 2010, 91, 389-393.
54. Stiasny, K.; Koessl, C.; Heinz, F.X. Involvement of lipids in different steps of the flavivirus fusion mechanism. J. Virol. 2003, 77, 7856-7862.
55. Umashankar, M.; Sanchez-San, M.C.; Liao, M.; Reilly, B.; Guo, A.; Taylor, G.; Kielian, M. Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J. Virol. 2008, 82, 9245-9253.
56. Poh, M.K.; Yip, A.; Zhang, S.; Priestle, J.P.; Ma, N.L.; Smit, J.M.; Wilschut, J.; Shi, P.Y.; Wenk, M.R.; Schul, W. A small molecule fusion inhibitor of dengue virus. Antiviral Res. 2009, 84, 260-266.
57. Schmidt, A.G.; Yang, P.L.; Harrison, S.C. Peptide inhibitors of dengue-virus entry target a latestage fusion intermediate. PLoS. Pathog. 2010, 6, e1000851.
58. Yu, I.M.; Holdaway, H.A.; Chipman, P.R.; Kuhn, R.J.; Rossmann, M.G.; Chen, J. Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J. Virol. 2009, 83, 12101-12107.
59. Das, S.; Chakraborty, S.; Basu, A. Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells. J. Neurochem. 2010, 115, 537-549.
60. Puerta-Guardo, H.; Mosso, C.; Medina, F.; Liprandi, F.; Ludert, J.E.; del Angel, R.M. Antibodydependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains. J. Gen. Virol. 2010, 91, 394-403.
61. Tani, H.; Shiokawa, M.; Kaname, Y.; Kambara, H.; Mori, Y.; Abe, T.; Moriishi, K.; Matsuura, Y. Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 2010, 84, 2798-2807.
62. Schlegel, R.; Tralka, T.S.; Willingham, M.C.; Pastan, I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983, 32, 639-646.
63. Coil, D.A.; Miller, A.D. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J. Virol. 2004, 78, 10920-10926.
64. Stegmann, T.; Hoekstra, D.; Scherphof, G.; Wilschut, J. Kinetics of pH-dependent fusion between influenza virus and liposomes. Biochemistry 1985, 24, 3107-3113.
65. Stegmann, T.; Hoekstra, D.; Scherphof, G.; Wilschut, J. Fusion activity of influenza virus. A comparison between biological and artificial target membrane vesicles. J. Biol. Chem. 1986, 261, 10966-10969.
66. Stegmann, T.; Nir, S.; Wilschut, J. Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes. Biochemistry 1989, 28, 1698-1704.
67. Stegmann, T.; Booy, F.P.; Wilschut, J. Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin. J. Biol. Chem. 1987, 262, 17744-17749.
68. Driessen, A.J.; Hoekstra, D.; Scherphof, G.; Kalicharan, R.D.; Wilschut, J. Low pH-induced fusion of liposomes with membrane vesicles derived from Bacillus subtilis. J. Biol. Chem. 1985, 260, 10880-10887.
69. Anderson, R.; Wang, S.; Osiowy, C.; Issekutz, A.C. Activation of endothelial cells via antibodyenhanced dengue virus infection of peripheral blood monocytes. J. Virol. 1997, 71, 4226-4232.
70. Cherrier, M.V.; Kaufmann, B.; Nybakken, G.E.; Lok, S.M.; Warren, J.T.; Chen, B.R.; Nelson, C.A.; Kostyuchenko, V.A.; Holdaway, H.A.; Chipman, P.R.; et al. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 2009, 28, 3269-3276.
71. He, R.T.; Innis, B.L.; Nisalak, A.; Usawattanakul, W.; Wang, S.; Kalayanarooj, S.; Anderson, R. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J. Med. Virol. 1995, 45, 451-461.
72. Putnak, R.; Cassidy, K.; Conforti, N.; Lee, R.; Sollazzo, D.; Truong, T.; Ing, E.; Dubois, D.; Sparkuhl, J.; Gastle, W.; et al. Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells. Am. J. Trop. Med. Hyg. 1996, 55, 504-510.
73. Se-Thoe, S.Y.; Ng, M.M.; Ling, A.E. Retrospective study of Western blot profiles in immune sera of natural dengue virus infections. J. Med. Virol. 1999, 57, 322-330.
74. Zybert, I.A.; van der Ende-Metselaar, H.H.; Wilschut, J.; Smit, J.M. Functional importance of dengue virus maturation: infectious properties of immature virions. J. Gen. Virol. 2008, 89, 3047-3051.
75. Randolph, V.B.; Winkler, G.; Stollar, V. Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology 1990, 174, 450-458.
76. Heinz, F.X.; Stiasny, K.; Puschner-Auer, G.; Holzmann, H.; Allison, S.L.; Mandl, C.W.; Kunz, C. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 1994, 198, 109-117.
77. Junjhon, J.; Edwards, T.J.; Utaipat, U.; Bowman, V.D.; Holdaway, H.A.; Zhang, W.; Keelapang, P.; Puttikhunt, C.; Perera, R.; Chipman, P.R.; et al. Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J. Virol. 2010, 84, 8353-8358.
78. Deubel, V.; Digoutte, J.P.; Mattei, X.; Pandare, D. Morphogenesis of yellow fever virus in Aedes aegypti cultured cells. II. An ultrastructural study. Am. J. Trop. Med. Hyg. 1981, 30, 1071-1077.
79. Hase, T.; Summers, P.L.; Eckels, K.H.; Baze, W.B. An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: maturation events. Arch. Virol. 1987, 92, 273-291.
80. Mackenzie, J.M.; Westaway, E.G. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 2001, 75, 10787-10799.
81. Ng, M.L. Ultrastructural studies of Kunjin virus-infected Aedes albopictus cells. J. Gen. Virol. 1987, 68, 577-582.
82. Welsch, S.; Miller, S.; Romero-Brey, I.; Merz, A.; Bleck, C.K.; Walther, P.; Fuller, S.D.; Antony, C.; Krijnse-Locker, J.; Bartenschlager, R. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host. Microbe 2009, 5, 365-375.
83. Yu, I.M.; Holdaway, H.A.; Chipman, P.R.; Kuhn, R.J.; Rossmann, M.G.; Chen, J. Structure of the immature dengue virus at low pH primes proteolytic maturation. J. Virol. 2009, 83, 12101-12107.
84. Wengler, G.; Wengler, G. Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J. Virol. 1989, 63, 2521-2526.
85. Zheng, A.; Umashankar, M.; Kielian, M. In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS. Pathog. 2010, 6, e1001157.
86. Stadler, K.; Allison, S.L.; Schalich, J.; Heinz, F.X. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 1997, 71, 8475-8481.
87. Dejnirattisai, W.; Jumnainsong, A.; Onsirisakul, N.; Fitton, P.; Vasanawathana, S.; Limpitikul, W.; Puttikhunt, C.; Edwards, C.; Duangchinda, T.; Supasa, S.; et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328, 745-748.
88. Rodenhuis-Zybert, I.A.; van der Schaar, H.M.; da Silva Voorham, J.; van der Ende-Metselaar, H.; Lei, H.Y.; Wilschut, J.; Smit, J.M. Immature dengue virus: a veiled pathogen? PLoS. Pathog. 2010, 6, e1000718.
89. Junjhon, J.; Lausumpao, M.; Supasa, S.; Noisakran, S.; Songjaeng, A.; Saraithong, P.; Chaichoun, K.; Utaipat, U.; Keelapang, P.; Kanjanahaluethai, A.; et al. Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J. Virol. 2008, 82, 10776-10791.
90. Nelson, S.; Jost, C.A.; Xu, Q.; Ess, J.; Martin, J.E.; Oliphant, T.; Whitehead, S.S.; Durbin, A.P.; Graham, B.S.; Diamond, M.S.; et al. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS. Pathog. 2008, 4, e1000060.